What’s In A PDUFA Reauthorization? Maybe These Issues…
You may also be interested in...
FDA Reform Bill Would Give Commissioner Fixed Term, Add Review Board
The Transforming the Regulatory Environment to Accelerate Access to Treatments Act would mandate a fixed six-year term for the FDA commissioner and the agency’s centers would receive a chief medical policy officer, according to a draft of the bill.
FDA Reform Bill Would Give Commissioner Fixed Term, Add Review Board
The Transforming the Regulatory Environment to Accelerate Access to Treatments Act would mandate a fixed six-year term for the FDA commissioner and the agency’s centers would receive a chief medical policy officer, according to a draft of the bill.
FDA Reform Bill Gives Commissioner Fixed Term, Adds Review Board
The Transforming the Regulatory Environment to Accelerate Access to Treatments (TREAT) Act would mandate a fixed six-year term for the FDA commissioner, according to a draft of the bill obtained by “The Pink Sheet.” FDA’s centers would receive a chief medical policy officer.